8/21/2025Zelgen Secures FDA IND Approval for Novel Trispecific Cancer Therapy

8/21/2025Novartis' Vanrafia (atrasentan) Gains Regulatory Nod in China as Secon...

8/21/2025Nicox Targets U.S. and China Filings After Second Phase III Win for NC...

8/21/2025Henlius Biotech Expands Oncology Portfolio with Strategic Licensing Ag...

8/21/2025China Proposes Conflict-of-Interest Declarations for Drug Clinical Tri...

8/21/2025China Drafts Guidance on Single-Arm Trials to Support Oncology Drug Ap...

8/20/2025China Drives Asia-Pacific Health Care Transformation Amid Rising Costs...

8/20/2025Vivatides Secures Major Seed Funding to Propel Breakthrough in Oligonu...

8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...

8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China

8/19/2025Onconic's GERD Drug Jaqbo Advances in China Following Phase 3 Success

8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval

8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025

8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...

8/19/2025Aeonvital Biomedical Advances Personalized Cancer Therapies with New F...

8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...

8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...

8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 

8/18/2025Pleryon Completes First Closing of Series A Financing

8/18/2025Yixuan Secures Angel Financing to Advance Novel Nucleic Acid Drug Deve...

8/18/2025Aoda Raises CNY30M Series A to Advance Dual-Receptor Agonist Program

8/18/2025Latticon Completes Series A Financing to Advance Trial of LAT010 Immun...

8/18/2025Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...

8/15/2025NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...

8/15/2025Guangzhou Innogen Pharma Debuts on HKSE Amid Expanding Metabolic Pipel...

8/14/2025CDE Seeks Public Input on Draft Guidelines for Bayesian Methods in Cli...

8/14/2025CDE Issues New Technical Guidelines for Clinical Development of Osteoa...

8/14/2025CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...

8/14/2025CDE Seeks Public Input on Draft Guidelines for Rare Disease Drug Devel...

8/14/2025Remegen's Telitacicept Achieves Phase III Success

Page:31/60 Total number of articles:1780: [First][<<] [29] [30] [31] [32] [33] [>>] [End]